Two Sigma Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,500
Closed -$123K 2179
2024
Q4
$123K Sell
13,500
-12,100
-47% -$117K 0.02% 1080
2024
Q3
$235K Sell
25,600
-99,200
-79% -$821K ﹤0.01% 2000
2024
Q2
$1.22M Buy
124,800
+77,900
+166% +$950K 0.01% 976
2024
Q1
$708K Sell
46,900
-1,100
-2% -$20K 0.01% 1333
2023
Q4
$1.03M Buy
48,000
+15,900
+50% +$293K 0.01% 1020
2023
Q3
$597K Sell
32,100
-96,300
-75% -$2.25M 0.01% 1404
2023
Q2
$3.25M Buy
128,400
+68,900
+116% +$1.73M 0.05% 420
2023
Q1
$1.54M Sell
59,500
-69,600
-54% -$1.86M 0.03% 633
2022
Q4
$3.05M Buy
129,100
+3,300
+3% +$89K 0.09% 287
2022
Q3
$3.19M Buy
125,800
+28,800
+30% +$1.01M 0.1% 258
2022
Q2
$3.22M Buy
97,000
+44,300
+84% +$1.88M 0.11% 198
2022
Q1
$3.8M Buy
+52,700
New +$3.8M 0.13% 180
2021
Q4
Sell
-20,100
Closed -$2.55M 2030
2021
Q3
$2.55M Buy
20,100
+4,800
+31% +$699K 0.07% 239
2021
Q2
$2.54M Buy
+15,300
New +$2.48M 0.08% 192

Other funds holding TDOC

Two Sigma Securities's TDOC Position: Q2 2025 in Review

Two Sigma Securities sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 12,790 shares — an estimated $102K sold.

Two Sigma Securities first reported a position in TDOC in Q4 2018 and held it in 12 quarters. The position peaked at $1.26M in Q1 2022. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Two Sigma Securities reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 12,790 Teladoc Health shares in Q2 2025, an estimated $102K.
  • Two Sigma Securities first reported a position in Teladoc Health in Q4 2018 and held it in 12 quarters.
  • Two Sigma Securities's Teladoc Health position peaked at $1.26M in Q1 2022.
  • 358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.